Filing Details
- Accession Number:
- 0001127602-19-008813
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-02-28 09:55:05
- Reporting Period:
- 2019-02-26
- Accepted Time:
- 2019-02-28 09:55:05
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1100682 | Charles River Laboratories International Inc | CRL | Services-Commercial Physical & Biological Research (8731) | 061397316 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1141722 | C James Foster | 251 Ballardvale Street Wilmington MA 01887 | Chairman, President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2019-02-26 | 200 | $143.41 | 282,801 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-02-26 | 200 | $143.42 | 282,601 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-02-26 | 100 | $143.47 | 282,501 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-02-26 | 400 | $143.58 | 282,101 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-02-26 | 30 | $143.72 | 282,071 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-02-26 | 100 | $143.76 | 281,971 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-02-26 | 100 | $143.85 | 281,871 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-02-26 | 300 | $143.85 | 281,571 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-02-26 | 100 | $144.19 | 281,471 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-02-26 | 100 | $144.59 | 281,371 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-02-27 | 2,171 | $140.71 | 279,200 | No | 4 | F | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | F | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 18,390 | Indirect | 2017 GRAT |
| Common Stock | 25,000 | Indirect | 2018 GRAT |
| Common Stock | 340 | Indirect | By Trust |
| Common Stock | 10,000 | Indirect | Held By Spouse |
Footnotes
- This sale occurred pursuant to a 10b5-1 Trading Plan.
Billionaire Hedge Funds
